Keywords: dainippon, sumitomo, launches, replagel, japan, tokyo, japan-based

Dainippon Sumitomo launches Replagel in Japan

Article | 26 February 2007

Tokyo, Japan-based Dainippon Sumitomo Pharma has launched Replagal (agalsidase-alfa [genetic recombination]) for Anderson-Fabry disease, a lysosomal storage disorder caused by ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Dainippon Sumitomo Pharma

Shire

Go to company listing